BIOBIJOU Co., Ltd. Logo

BIOBIJOU Co., Ltd.

Develops and manufactures medical aesthetic products like H.A. fillers and skincare.

489460 | KO

Overview

Corporate Details

ISIN(s):
KR7489460006
LEI:
Country:
South Korea
Address:
경기도 하남시 하남대로 947 에이동 1516호, 하남시

Description

BIOBIJOU Co., Ltd. is a biotechnology company that researches, develops, manufactures, and distributes medical aesthetic and healthcare products. The company's portfolio primarily consists of hyaluronic acid (H.A.)-based dermal fillers, injectable skin boosters, fat-dissolving solutions, and a range of cosmetic skincare items. BIOBIJOU operates across the entire value chain, from initial product development to global sales, employing automated production facilities and rigorous quality control systems. The company serves a global market, with an established international sales network and a significant distribution presence in China. It focuses on technological research and development to provide stable and high-quality products for the skincare and wellness sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-12-16 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.8 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-05-20 00:00
주식등의대량보유상황보고서(일반)
Korean 89.4 KB
2025-05-20 00:00
주식등의대량보유상황보고서(약식)
Korean 64.8 KB
2025-05-20 00:00
주식등의대량보유상황보고서(약식)
Korean 64.9 KB
2025-05-13 00:00
증권발행실적보고서
Korean 211.9 KB
2025-05-02 00:00
[발행조건확정]증권신고서(지분증권)
Korean 495.1 KB
2025-05-02 00:00
[기재정정]투자설명서
Korean 3.6 MB
2025-04-29 00:00
투자설명서
Korean 3.1 MB
2025-04-18 00:00
[기재정정]증권신고서(지분증권)
Korean 3.1 MB
2025-04-07 00:00
[기재정정]증권신고서(지분증권)
Korean 4.0 MB
2025-03-24 00:00
[기재정정]감사보고서 (2024.12)
Korean 493.5 KB
2025-03-24 00:00
[기재정정]연결감사보고서 (2024.12)
Korean 504.6 KB
2025-03-24 00:00
증권신고서(지분증권)
Korean 3.0 MB

Automate Your Workflow. Get a real-time feed of all BIOBIJOU Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOBIJOU Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOBIJOU Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.